scholarly journals Pathologic changes in patients infected with SARS-CoV-2: a review

2021 ◽  
Vol 22 (4) ◽  
pp. 423-429
Author(s):  
M. Babazhitsu ◽  
O.O. Adegoke ◽  
S.A. Abayomi ◽  
B. Adegboro
Keyword(s):  
Immune Responses ◽  
Literature Search ◽  
The Body ◽  
Prise En Charge ◽  
Post Mortem ◽  
Pathological Changes ◽  
Immunomodulatory Agents ◽  
Angiotensin Converting Enzyme 2 ◽  
Host Immune Responses ◽  
Résultats Cliniques

Severe acute respiratory syndrome–coronavirus-2 (SARS-CoV-2) enters cells using the angiotensin converting enzyme 2 (ACE2), which are expressed by the respiratory tract endothelium, epithelial cells of the stomach, duodenum, ileum, rectum, cholangiocytes, and hepatocytes. Pathological examinations of these organs are not feasible method of diagnosis but can explain pathological changes, pathogenesis of the disease, and the cause of death in COVID-19 cases. In this review, we performed a literature search for COVID-19-related pathological changes seen during post-mortem examinations in different organs of the body including the lungs, gastrointestinal tract, liver, kidney, skin, heart and blood. Our findings showed that SARS-CoV-2 has damaging effects on many organs, probably due to the host immune responses to the presence of the virus. It is recommended that both antiviral and immunomodulatory agents should be considered in the management of COVID-19 patients for better prognosis, and clinical outcome.   French title: Changements pathologiques chez les patients infectés par le SRAS-CoV-2: une revue Le syndrome respiratoire aigu sévère-coronavirus-2 (SARS-CoV-2) pénètre dans les cellules à l'aide de l'enzyme de conversion de l'angiotensine 2 (ACE2), qui est exprimée par l'endothélium des voies respiratoires, les cellules épithéliales de l'estomac, du duodénum, de l'iléon, du rectum, des cholangiocytes, et les hépatocytes. Les examens pathologiques de ces organes ne sont pas une méthode de diagnostic réalisable, mais peuvent expliquer les changements pathologiques, la pathogenèse de la maladie et la cause du décès dans les cas de COVID-19. Dans cette revue, nous avons effectué une recherche bibliographique sur les changements pathologiques liés au COVID-19 observés lors d'examens post-mortem dans différents organes du corps, notamment les poumons, le tractus gastro-intestinal, le foie, les reins, la peau, le coeur et le sang. Nos résultats ont montré que le SRAS-CoV-2 a des effets néfastes sur de nombreux organes, probablement en raison des réponses immunitaires de l'hôte à la présence du virus. Il est recommandé que les agents antiviraux et immunomodulateurs soient pris en compte dans la prise en charge des patients COVID-19 pour un meilleur pronostic et des résultats cliniques.  

Role of convalescent plasma therapy in new Coronavirus disease (nCOVID-19): A review

2020 ◽  
Vol 11 (SPL1) ◽  
pp. 546-549
Author(s):  
Shweta Dadarao Parwe ◽  
Milind Abhimanyu Nisargandha ◽  
Rishikesh Thakre
Keyword(s):  
Clinical Trial ◽  
Immune Responses ◽  
Indian Population ◽  
Preventive Treatment ◽  
The Body ◽  
Therapeutic Antibodies ◽  
Plasma Therapy ◽  
Host Immune Responses ◽  
Transparent Liquid

Hitherto, there is no proper line of treatment for the new (nCOVID19). The development of unique antiviral drugs has taken precedence. Therapeutic antibodies () will be a significantly beneficial agent against nCOVID-19. Here the host immune responses to new discussed in this review provide strategy and further treatment and understanding of clinical interventions against nCOVID-19. Plasma therapy uses the antibodies found in the blood of people recovering (or convalesced) from an infection to treat infected patients. When an infection occurs, the body begins producing proteins specially made to kill the germ, called antibodies. Those antibodies coat specifically plasma in the blood of survivors, the yellow transparent liquid blood portion for months or even years. research assesses plasma use from Convalescent patients of infected with nCOVID-19 as a possible preventive treatment. But it is not yet recommended as a line of treatment, and it is used as a clinical trial in the new in Indian population.

Porous Materials for Immune Modulation

2018 ◽  
Vol 4 (1) ◽  
pp. 1-14
Author(s):  
Moonkyoung Jeong ◽  
Hansol Kim ◽  
Ji-Ho Park
Keyword(s):  
Immune Responses ◽  
Porous Materials ◽  
Immune Modulation ◽  
Pore Space ◽  
The Body ◽  
Immunomodulatory Agents ◽  
Recent Developments ◽  
Future Direction ◽  
Antigen Presenting ◽  
Immunomodulatory Potential

Abstract Biocompatible materials have a great potential to engineer immunology towards therapeutic applications. Among them, porous materials have attracted much attention for immune modulation due to their unique porous structure. The large surface area and pore space offer high loading capacity for various payloads including peptides, proteins and even cells. We first introduce recent developments in the porous particles that can deliver immunomodulatory agents to antigen presenting cells for immunomodulation. Then, we review recent developments in the porous implants that can act as a cellattracting/ delivering platform to generate artificial immunomodulatory environments in the body. Lastly, we summarize recent findings of immunogenic porous materials that can induce strong immune responses without additional adjuvants. We also discuss future direction of porous materials to enhance their immunomodulatory potential for immunotherapeutic applications.

scholarly journals Therapeutic Approaches for COVID-19 Based on the Interferon-mediated Immune Responses

2021 ◽  
Vol 16 ◽  
Author(s):  
Pouria Mosaddeghi ◽  
Farbod Shahabinezhad ◽  
Zahra Dehghani ◽  
Mitra Farahmandnejad ◽  
Mohammad Javad Taghipour ◽  
...  
Keyword(s):  
Immune System ◽  
Immune Responses ◽  
Genetic Similarity ◽  
The Body ◽  
Therapeutic Approaches ◽  
Host Immune Responses ◽  
Antiviral Responses ◽  
Interferon Induction ◽  
Optimum Approach ◽  
Novel Virus

Background: As the outbreak of COVID-19 has accelerated, an urgent need for finding strategies to combat the virus is growing. Thus, gaining more knowledge on the pathogenicity mechanism of SARS-CoV-2, the causing agent of COVID-19, and its interaction with the immune system is of utmost importance. Although this novel virus is not well known yet, its structural and genetic similarity with SARS-CoV as well as the comparable pattern of age-mortality relations suggest that some previous findings on SARS could be applicable for COVID-19. Objective: The aim of this study was to investigate the most important signaling pathways activated by coronaviruses to better understand the viral pathogenesis and host immune responses. Method: Here, a systems biology study was conducted on a SARS database. It was followed by a literature review on the cognate subject. Results: It was proved that interferons may possess a crucial role in the defense against coronavirus diseases. The literature supported the validity of the employed approach and the notion that interferon induction could play a key role in the body defense against coronavirus infections. Conclusion: Altogether, administration of interferons or interferon-inducing agents in a prophylactic manner or at early stages of the disease, could mimic the effective antiviral responses against SARS-CoV-2 and reduce the disease severity. At later stages of the disease, however, the balance of the immune reactions would be disrupted and the responses would shift toward immunopathogenic over-reactions, which could be exacerbated by interferon usage. Moderating the activity of the immune system by anti-inflammatory agents, might be the optimum approach in such conditions.

scholarly journals Mini-Review: SARS-CoV-2 and COVID-19

2021 ◽  
pp. 7-13
Keyword(s):  
Immune Responses ◽  
International Committee ◽  
Unknown Etiology ◽  
Study Group ◽  
Wuhan City ◽  
Angiotensin Converting Enzyme 2 ◽  
Host Immune Responses ◽  
Worldwide Distribution ◽  
Close Relationship ◽  
Novel Coronavirus

On 31 December 2019, the cases of pneumonia caused by unknown etiology had emerged. These cases were reported in Wuhan city, Hubei Province of China. Chinese authorities identified the causative agent and announced to be a novel coronavirus. The tentative name of disease is COVID-19, abbreviating of coronavirus disease-19. The incubation period of the disease ranges from 2 to 14 days, however, 80% of the patients have mild or asymptomatic illness while 15 % and 5% of the patients had exhibited sever and critical cases respectively. The etiology of COVID-19 was known as SARS-CoV-2 and belongs to betacoranviruse as reported by the International Committee on Taxonomy of Viruses (ICTV) especially Coronaviridae Study Group (CSG). In addition, this virus is currently believed to be within bat-coronaviruses besides it possesses a close relationship with SARS-CoV more than MERS-CoV. Although, the majority of the diagnosed patients had symptoms, there were asymptomatic persons who can spread the SARS-CoV-2. Upon the emergence of worldwide distribution of this virus, the WHO had declared it as a global outbreak and pandemic. Unfortunately, at present time, there are neither vaccine and nor an approved COVID-19 specific drug against SARS-CoV-2. One of the remarkable pathogenesis mechanistic step of this virus is taking possession of the affinity to angiotensin-converting enzyme 2 (ACE2). This mini-review summarizes the origin and molecular identification of the virus as well as the host immune responses. SARS-CoV-2 , COVID-19, ACE2, origin

scholarly journals Fungal Toxins and Host Immune Responses

2021 ◽  
Vol 12 ◽  
Author(s):  
Rhys Brown ◽  
Emily Priest ◽  
Julian R. Naglik ◽  
Jonathan P. Richardson
Keyword(s):  
Immune Responses ◽  
Experimental Models ◽  
The Body ◽  
Natural Environments ◽  
Immune Recognition ◽  
Microbial Infection ◽  
Ongoing Research ◽  
Host Immune Responses ◽  
Fungal Toxins ◽  
Peptide Toxins

Fungi are ubiquitous organisms that thrive in diverse natural environments including soils, plants, animals, and the human body. In response to warmth, humidity, and moisture, certain fungi which grow on crops and harvested foodstuffs can produce mycotoxins; secondary metabolites which when ingested have a deleterious impact on health. Ongoing research indicates that some mycotoxins and, more recently, peptide toxins are also produced during active fungal infection in humans and experimental models. A combination of innate and adaptive immune recognition allows the host to eliminate invading pathogens from the body. However, imbalances in immune homeostasis often facilitate microbial infection. Despite the wide-ranging effects of fungal toxins on health, our understanding of toxin-mediated modulation of immune responses is incomplete. This review will explore the current understanding of fungal toxins and how they contribute to the modulation of host immunity.

scholarly journals Microvascular Skin Manifestations Caused by COVID-19

2021 ◽  
Vol 41 (05) ◽  
pp. 387-396
Author(s):  
Andrea Gawaz ◽  
Emmanuella Guenova
Keyword(s):  
Immune Responses ◽  
Skin Lesions ◽  
Vascular Lesions ◽  
Small Vessel Vasculitis ◽  
Angiotensin Converting Enzyme 2 ◽  
Clinical Appearance ◽  
Host Immune Responses ◽  
Skin Manifestations ◽  
Multiple Organs ◽  
Pathophysiologic Mechanisms

AbstractHypercoagulability and vascular injury, which characterize morbidity in COVID-19 disease, are frequently observed in the skin. Several pathomechanisms, such as inflammation caused by angiotensin-converting enzyme 2–mediated uptake into endothelial cells or SARS-CoV-2-initiated host immune responses, contribute to microthrombus formation and the appearance of vascular skin lesions. Besides pathophysiologic mechanisms observed in the skin, this review describes the clinical appearance of cutaneous vascular lesions and their association with COVID-19 disease, including acro-ischemia, reticular lesions, and cutaneous small vessel vasculitis. Clinicians need to be aware that skin manifestations may be the only symptom in SARS-CoV-2 infection, and that inflammatory and thrombotic SARS-CoV-2-driven processes observed in multiple organs and tissues appear identically in the skin as well.

scholarly journals PREVALENCE OF F. gigantica AND PATHOLOGICAL CHANGES IN LIVER OF SIMEULUE BUFFALO

2017 ◽  
Vol 2 (1) ◽  
pp. 8-11
Author(s):  
Ikwan Jamil ◽  
Teuku Reza Ferasyi ◽  
Muhammad Hambal ◽  
Yudha Fahrimal ◽  
Razali Razali
Keyword(s):  
Bile Duct ◽  
Oil Palm ◽  
The Body ◽  
The Other ◽  
Post Mortem ◽  
Pathological Changes ◽  
Sharp Edges ◽  
Macroscopic Approach ◽  
High Degree ◽  
Very High

The aim of this study was to identify the prevalence of fasciolosis of Simeulue’s buffalo using macroscopic approach by observing pathological changes in the liver. The sample were obtained from slaughterhouse in Sinabang. A number of 60 livers were obtained on July to September 2015 based on post mortem examination. From this sample, a total of 57 livers were found positive indication of infested by F. gigantica (95%). The length and width of F. gigantica was 25 mm and 7 mm. The body was flat as a leaf, blunt on posterior, gray, brown, transparant and do not have a real shoulder shapes. The liver which were not  infested with F. gigantica showed sharp edges and a very high degree of elasticity. On the other hand, in the infested liver was found F. gigantica in the bile duct and showed a color of pale, the dark brown exudate as well as objects looks like gravel. The buffaloes sample were supplied to the abattoir from the paddy fields or oil palm plantations area. In comparison, the buffaloes raised in both areas were not different on the pathological changes of liver. In conclusion, this study showed that simeulue’s buffalo is very prevalence to F. gigantica.

scholarly journals Hyperinflammation Syndrome in COVID-19 Disease: Pathogenesis and Potential Immunomodulatory Agents

2021 ◽  
Author(s):  
Moulid Hidayat ◽  
Diah Handayani ◽  
Fariz Nurwidya ◽  
Sita Laksmi Andarini
Keyword(s):  
Immune Response ◽  
Immune Responses ◽  
Distress Syndrome ◽  
Multiorgan Failure ◽  
Immunosuppressive Agents ◽  
Clinical Manifestations ◽  
Disease Pathogenesis ◽  
Immunomodulatory Agents ◽  
Host Immune Responses ◽  
The World

The coronavirus disease 2019 (COVID-19) pandemic caused by infection of the SARS-CoV-2 virus has affected millions of people in the world. The pathogenesis and clinical manifestations of COVID-19 disease are tightly influenced by the host immune response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. In some condition, the immune response might be uncontrolled, giving rise to hyperinflammatory conditions marked by excessive release of proinflammatory cytokines (cytokine storms) in severe COVID-19 patients, which then can cause acute respiratory distress syndrome (ARDS), multiorgan failure, and death. Furthermore, treatment using immunomodulator agents including immunostimulatory and immunosuppressive agents can be an option in achieving successful treatment. In this review, we discuss the pathogenesis of the disease, including host immune responses to SARS-CoV-2 virus infection, and immune mechanisms which contribute to the disease severity and death as well as several potential immunomodulatory agents which can be used in the management of hyperinflammatory syndrome of severe COVID-19.

Sign in / Sign up

Export Citation Format

Share Document